Cargando…
Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019
The objective of this study is to provide comprehensive and up-to-date estimates on the disease burden of BPH in 204 countries and territories between 1990 and 2019. Data about incidence, year lived with disability (YLD), and their age-standardized rates (ASRs) for 21 regions, 5 Socio-demographic In...
Autores principales: | Xu, Xiao-Feng, Liu, Guo-Xiong, Guo, Ya-Shou, Zhu, Hai-Yun, He, Da-Lin, Qiao, Xi-Min, Li, Xu-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326634/ https://www.ncbi.nlm.nih.gov/pubmed/34330182 http://dx.doi.org/10.1177/15579883211036786 |
Ejemplares similares
-
Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients
por: Li, Bing-Hui, et al.
Publicado: (2019) -
Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
por: Cai, Tong, et al.
Publicado: (2020) -
Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin
Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia
and Erectile Dysfunction
por: Zhou, Zhongbao, et al.
Publicado: (2019) -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
Treatment: A Russian Multicenter Study in More Than 1,000 Treated
Patients
por: Kamalov, Armais, et al.
Publicado: (2020) -
The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis
por: Sun, Fengze, et al.
Publicado: (2022)